Neurogene Inc. (NASDAQ: NGNE)
$18.0350
+2.4450 ( +16.51% ) 360.5K
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
Market Data
Open
$18.0350
Previous close
$15.5900
Volume
360.5K
Market cap
$231.59M
Day range
$14.6970 - $18.3980
52 week range
$12.4900 - $74.4900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 52 | May 10, 2024 |
| 8-k | 8K-related | 15 | May 07, 2024 |
| def | Proxies and info statements | 22 | Apr 26, 2024 |
| ars | Annual reports | 1 | Apr 26, 2024 |
| 8-k | 8K-related | 13 | Apr 25, 2024 |
| 8-k | 8K-related | 15 | Apr 22, 2024 |
| 8-k | 8K-related | 13 | Apr 02, 2024 |
| 10-k | Annual reports | 121 | Mar 18, 2024 |
| 8-k | 8K-related | 15 | Mar 18, 2024 |
| 4 | Insider transactions | 1 | Mar 14, 2024 |